JPRN-UMIN000015695已完成未知
Combination therapy of IFN plus IL-2 for patients with mRCC after failed molecular targeted therapy - IFN and IL-2 for mRCC
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 入组人数
- 10
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional,observational
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •-allergy for IFN or IL-2 -allergy for any vaccine -Patient using Shosaikoto (Ref. Std. Kampo Nomenclature). -Auto-immune disease -interstitial pneumonia -pregnant -long lasting steroids usage -brain mets -any pts doctor felt unfit the trial
研究者
相似试验
已完成
不适用
Efficacy of combination therapy IFN-alpha-2b and ribavirin for patients with Serogroup2 and high titer HCV / without Serogroup1 and high titer HCV.Hepatitis CJPRN-C000000196Osaka university graduate school of medicine200
已完成
不适用
Efficasy of combination therapy PEG-IFN-alpha-2b and Ribavirin for patients with Serogroup1 and high titer HCV.Hepatitis CJPRN-C000000197Osaka university graduate school of medicine500
已完成
不适用
Peg-IFN-alfa-2b/Ribavirin combination therapy for chronic hepatitis C patients: Effectiveness prediction by gene analysis and efficacy with Fluvastatin combinatiochronic hepatitis CJPRN-UMIN000008196Kanazawa University200
已完成
不适用
The combination therapy of PEG-IFN alpha 2b, Ribavirin and Telaprevir for the patients with chronic hepatitis C:the study for treatment duration by response guided therapy and prediction of efficacy by gene analysis in Japan.chronic hepatitis CJPRN-UMIN000018971agoya university500
招募中
不适用
Combination therapy of interferon-alpha and interleukin-2 for patients with metastatic renal cell carcinoma after failure of targeted therapy because of adverse eventsJPRN-UMIN000017717Department of Urology, The University of Tokyo Hospital30